Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging

Yoshihisa Hasegawa(Osaka Medical Center for Cancer and Cardiovascular Diseases), S. Ishigami(Osaka Medical Center for Cancer and Cardiovascular Diseases), Yo Sasaki(SHOWA Medical University), Terumi Hashizume(Osaka Medical Center for Cancer and Cardiovascular Diseases), Makoto Fujita(Osaka University), Shunnichi Nakano(Osaka Medical Center for Cancer and Cardiovascular Diseases), Keijiro Ibuka(Osaka Medical Center for Cancer and Cardiovascular Diseases), Hiroshi Kasugai(Osaka International Cancer Institute), Seiichi Kawamoto(Osaka Medical Center for Cancer and Cardiovascular Diseases), Shingi Imaoka(Osaka International Cancer Institute), Atsushi Noguchi(Osaka Medical Center for Cancer and Cardiovascular Diseases), Jyunnosuke Kojima(Osaka Medical Center for Cancer and Cardiovascular Diseases), Sachiko Tanaka(Osaka International Cancer Institute)
Cancer
January 15, 1986
10.1002/1097-0142(19860115)57:2<230::aid-cncr2820570208>3.0.co;2-w
Cited by 19

Related Papers

Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899
The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration
|Neuron|2017|641